S. Provent

500 total citations
7 papers, 365 citations indexed

About

S. Provent is a scholar working on Surgery, Oncology and Reproductive Medicine. According to data from OpenAlex, S. Provent has authored 7 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 4 papers in Oncology and 3 papers in Reproductive Medicine. Recurrent topics in S. Provent's work include Ovarian cancer diagnosis and treatment (3 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers). S. Provent is often cited by papers focused on Ovarian cancer diagnosis and treatment (3 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers). S. Provent collaborates with scholars based in France, United States and Luxembourg. S. Provent's co-authors include Jean‐Pierre Lotz, Frédèric Selle, Christophe Louvet, Armand de Gramont, Thierry André, Christophe Tournigand, D. Avenin, Brice Gayet, L Hannoun and Olivier Rosmorduc and has published in prestigious journals such as Annals of Oncology, European Journal of Cancer and Bone Marrow Transplantation.

In The Last Decade

S. Provent

7 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Provent France 4 320 220 212 35 31 7 365
Wen‐Yih Liang Taiwan 10 153 0.5× 202 0.9× 80 0.4× 39 1.1× 13 0.4× 17 353
Ahmed Khalil France 9 117 0.4× 127 0.6× 103 0.5× 16 0.5× 23 0.7× 33 290
Caroline Lum Australia 8 202 0.6× 309 1.4× 80 0.4× 73 2.1× 14 0.5× 13 398
Giorgio Papiani Italy 11 167 0.5× 103 0.5× 64 0.3× 82 2.3× 20 0.6× 19 270
Rajiv Datta United States 11 182 0.6× 104 0.5× 74 0.3× 25 0.7× 4 0.1× 19 372
Daisuke Takayanagi Japan 11 119 0.4× 245 1.1× 143 0.7× 29 0.8× 6 0.2× 35 384
Jaewon Hyung South Korea 8 195 0.6× 169 0.8× 151 0.7× 8 0.2× 10 0.3× 32 272
Wadad Mneimneh United States 10 86 0.3× 97 0.4× 79 0.4× 46 1.3× 41 1.3× 36 284
Hideaki Shimoji Japan 13 296 0.9× 140 0.6× 209 1.0× 13 0.4× 12 0.4× 30 422
John Theodorus Plukker Netherlands 11 244 0.8× 131 0.6× 161 0.8× 5 0.1× 9 0.3× 26 458

Countries citing papers authored by S. Provent

Since Specialization
Citations

This map shows the geographic impact of S. Provent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Provent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Provent more than expected).

Fields of papers citing papers by S. Provent

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Provent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Provent. The network helps show where S. Provent may publish in the future.

Co-authorship network of co-authors of S. Provent

This figure shows the co-authorship network connecting the top 25 collaborators of S. Provent. A scholar is included among the top collaborators of S. Provent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Provent. S. Provent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Selle, Frédèric, Patricia Pautier, Catherine Lhommé, et al.. (2015). A Phase I Trial of High-Dose Chemotherapy Combining Topotecan plus Cyclophosphamide with Hematopoietic Stem Cell Transplantation for Ovarian Cancer: The ITOV 01bis Study. Chemotherapy. 61(1). 15–22. 1 indexed citations
2.
Selle, Frédèric, Joseph Gligorov, Sandrine Richard, et al.. (2014). Intensive chemotherapy as salvage treatment for solid tumors: focus on germ cell cancer. Brazilian Journal of Medical and Biological Research. 48(1). 13–24. 4 indexed citations
3.
Pautier, Patricia, Frédèric Selle, Patrice Viens, et al.. (2006). Phase I study of high-dose topotecan with haematopoietic stem cell support in the treatment of ovarian carcinomas: the ITOV 01 protocol. Bone Marrow Transplantation. 37(7). 669–675. 3 indexed citations
4.
5.
André, Thierry, Christophe Tournigand, Olivier Rosmorduc, et al.. (2004). Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study. Annals of Oncology. 15(9). 1339–1343. 309 indexed citations
6.
7.
André, Thierry, Christophe Louvet, Pascal Artru, et al.. (2001). A phase II study of gemcitabine and oxaliplatin (gemox) in advanced biliary adenocarcinoma (ABA). Preliminary results. European Journal of Cancer. 37. S19–S19. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wen‐Yih Liang Breakdown of academic impact, for papers by Ahmed Khalil Breakdown of academic impact, for papers by Caroline Lum Breakdown of academic impact, for papers by Giorgio Papiani Breakdown of academic impact, for papers by Rajiv Datta Breakdown of academic impact, for papers by Daisuke Takayanagi Breakdown of academic impact, for papers by Jaewon Hyung Breakdown of academic impact, for papers by Wadad Mneimneh Breakdown of academic impact, for papers by Hideaki Shimoji Breakdown of academic impact, for papers by John Theodorus Plukker
Rankless by CCL
2026